DMD America Inc.
Fayetteville, NY
- UEI
- Z3MMLCHME8E9
- CAGE
- 78KA5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 100 Limestone Plaza Unit 20, Manlius, NY 13066, USA
- Website
- analysource.com
- Founded
- 1996
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 89 Services, Not Elsewhere Classified
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Analysource license agreement | Assistant Secretary for Financial Resources | $62,285 | |
| Analysource license agreement | Office of the Assistant Secretary for Administration | $60,471 | |
| Analysource US prescription drug pricing data purchase | Office of the Assistant Secretary for Administration | $58,710 | |
| On-demand list price look up tool for pharmaceuticals, for initial screening of drugs or markets with potential monopoly… | Office of the Assistant Secretary for Administration | $57,000 | |
| To renew three one year analysource licenses | Office of the Assistant Secretary for Administration | $63,241 |
About DMD America Inc.
DMD America Inc. is a for-profit Subchapter S Corporation headquartered in Manlius, New York, that specializes in providing pharmaceutical pricing intelligence and analytical tools to the federal government. Registered in SAM.gov since October 2014, the company has established itself as a key vendor for the U.S. Department of Health and Human Services by delivering critical data and software solutions that support government oversight of prescription drug pricing markets. DMD America Inc. operates in the specialized domain of pharmaceutical pricing analytics, offering comprehensive U.S. prescription drug pricing data and analytical platforms that enable federal agencies to monitor market trends and identify potential monopolistic pricing actions within the pharmaceutical industry.
DMD America Inc. has secured a consistent stream of federal contract awards from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Administration, dating back to June 2022. The company has delivered four separate firm fixed-price purchase order contracts, all competed on a full and open competition basis with no set-aside designations, totaling approximately $238,466 in cumulative contract value. These awards include the AnalySource license agreement (valued at $62,285 through August 2026 and $60,471 through June 2025), the AnalySource US Prescription Drug Pricing Data Purchase ($58,710 through June 2024), and an on-demand list price lookup tool for pharmaceuticals ($57,000 through June 2023). All contracts have been performed primarily in support of HHS's drug pricing oversight activities, with performance locations including Washington, DC and Fayetteville, New York. The consistent renewal and expansion of these contracts demonstrates the federal government's reliance on DMD America Inc.'s AnalySource platform as an essential resource for monitoring and analyzing prescription drug pricing dynamics and evaluating potential anticompetitive market conduct.
Quick answers
What is DMD America Inc.'s UEI?
DMD America Inc.'s Unique Entity ID (UEI) in SAM.gov is Z3MMLCHME8E9.
What is DMD America Inc.'s CAGE code?
DMD America Inc.'s CAGE code is 78KA5.
What is DMD America Inc.'s primary NAICS code?
DMD America Inc.'s primary NAICS code is 519290 (Web Search Portals and All Other Information Services).
Where is DMD America Inc. located?
DMD America Inc.'s physical address in SAM.gov is 100 Limestone Plaza Unit 20, Manlius, NY 13066, USA.
Is DMD America Inc. registered in SAM.gov?
Yes. DMD America Inc.'s SAM.gov registration is active through July 29, 2027.
What is DMD America Inc.'s most recent federal award?
DMD America Inc.'s most recent federal contract award is Analysource license agreement (75P00125P00065), from Assistant Secretary for Financial Resources, on August 15, 2025.
On GovTribe
See DMD America Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors